Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis

Full text for this resource is not available from the Research Repository.

Rodi, M, de Lastic, AL, Antonopoulou, S, Kylintireas, C, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Matsoukas, J and Mouzaki, A (2019) Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 33 (3). pp. 92-93. ISSN 1011-6583

Item type Article
URI https://vuir.vu.edu.au/id/eprint/41133
Subjects Current > FOR Classification > 1107 Immunology
Current > Division/Research > College of Health and Biomedicine
Keywords autoimmune disease; central nervous system; immunological tolerance; T cell tolerance
Citations in Scopus 0 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login